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Lab-on-a-Chip implants: 
a mini-lab under the skin 
Labopuce implantable sous cutanée: 
un mini-laboratoire sous la peau 
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Objectives 
  Continuous real-time monitoring of 
chronic patients 
  Current devices are external and 
limited to a single measurement 
  Tracking multiple metabolites 
  Wireless, batteryless implant 
  Driver technology for a wide  
set of applications 
Prototype: implant 
20 x 4.2 x 3 mm 
Prototype: external patch 
FEATURES 
Remote powering through inductive link 
Short-range bidirectional communication 
Long-range comm. with remote devices 
ADVANTAGES 
Improved wearability 
Direct placement over implant area 
Stand alone 
Battery-powered 
6 
       Android User Interface 
  Motivation, objectives and overview 
  The nanobiosensor technology 
  Control and readout circuit for multi-
target biosensing 
  Microelectronic circuits for data 
acquisition and energy harvesting 
  System biocompatibility  
  Conclusions and outlook 
Outline 
CARBON NANOTUBES 
CNTs + PROBE ENZYMES 
The nanobiosensor concept 
Carbon nanotube benefits 
 Sensor sensitivity is enhanced by 
CNT nanostructuration 
~ 7.5 times more  
Nanobiosensors sensitivity and range 
Metabolite Sensitivity 
(µA/mM cm2) 
Range  
(mM) 
Detection limit  
(S/N = 3σ)    (µM) 
Glucose 27.7 0.5 – 4 73 
Lactate 40.1 0.5 – 2.5 28 
Glutamate 25.5 0.5 – 2 195 
ATP 3.42 0.5 – 1.4 208 
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Layout of the fabricated IC 
(0.18um technology) 
  A biosensing platform 
  Low power 
  Remotely powered 
  Flexible and programmable 
  High accuracy 
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Inductive Link 
  Wireless power transfer through inductive link 
  Bidirectional data communication 
IronIC Patch 
Power Transmission 
Battery Life 
  Up to 15 mW transmitted within 6 mm in air 
  Downlink communication up to 100 kbps 
  Bluetooth communication (Class-2) 
  Uplink communication up to 66.6 kbps 
  Stand-by mode: 10 hours 
  Power mode: 1.5 hours 
  Up to 1.2 mW transmitted within 17 mm  
   tissue 
Data Transmission 
Multi-layer Receiving Inductors 
  Higher link efficiency (up to 35% higher) 
  Higher voltage gain (up to one order of      
magnitude higher) 
Power & Data Transmission 
Downlink Bitstream  – 100 kbps Uplink Bitstream  – 66.6 kbps 
Power 
Data 
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Challenges 
Prevent Cu leaking (coil) 
 Prevent CNT diffusion (sensors) 
 Prevent circuit corrosion 
Prevent sensors biofouling 
Investigations:  
 Cytotoxicity tests 
 In-vivo tests 
Solutions: 
 Parylene C inner coating 
USP class 6 Silicone external coating 
CNT entrapement in chitosan + outer 
membrane 
Biocompatibility 
In vivo inflammation 
•  Subcutaneous implant in mice 
•  No significant inflammation after 30 days 
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Conclusions 
  Continuous care of chronic patients is possible 
through specialized bio-electronics 
  Significant improvement over the state of the art: 
   FDA-approved wearable glucose monitoring systems 
  Electronic implants represent a near-future 
technology and can be more patient-friendly 
  Challenges include the plurality of technologies as 
well as the interaction with the human body 
Thank you 
  Sandro Carrara 
  Catherine Dehollain 
  Fabio Grassi 
  Linda Thoeny-Meyer 
  Yusuf Leblebici 
  Qiuting Huang 
  Andrea Cavallini  
  Sara Seyedeh  
  Irene Taurino  
  Jacopo Olivo  
  Kazanc Onur  
  Tanja Rezzonico  
  Michele Proietti  
  Renate Reiss  
  Michael Richter  
  Michael Fairhead 
Thank you 
